ATE89281T1 - Morpholin-derivate, deren verfahren zur herstellung und sie enthaltende pharmazeutische zusammensetzungen. - Google Patents

Morpholin-derivate, deren verfahren zur herstellung und sie enthaltende pharmazeutische zusammensetzungen.

Info

Publication number
ATE89281T1
ATE89281T1 AT88400693T AT88400693T ATE89281T1 AT E89281 T1 ATE89281 T1 AT E89281T1 AT 88400693 T AT88400693 T AT 88400693T AT 88400693 T AT88400693 T AT 88400693T AT E89281 T1 ATE89281 T1 AT E89281T1
Authority
AT
Austria
Prior art keywords
production
pharmaceutical compositions
compositions containing
morpholine derivatives
aralkyl
Prior art date
Application number
AT88400693T
Other languages
English (en)
Inventor
Gilbert Regnier
Claude Guillonneau
Jean Lepagnol
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Application granted granted Critical
Publication of ATE89281T1 publication Critical patent/ATE89281T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Control For Baths (AREA)
  • Earth Drilling (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT88400693T 1987-03-24 1988-03-23 Morpholin-derivate, deren verfahren zur herstellung und sie enthaltende pharmazeutische zusammensetzungen. ATE89281T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8704047A FR2612926B1 (fr) 1987-03-24 1987-03-24 Nouveaux derives de la morpholine, leur procede de preparation et les compositions pharmaceutiques les renfermant
EP88400693A EP0286495B1 (de) 1987-03-24 1988-03-23 Morpholin-Derivate, deren Verfahren zur Herstellung und sie enthaltende pharmazeutische Zusammensetzungen

Publications (1)

Publication Number Publication Date
ATE89281T1 true ATE89281T1 (de) 1993-05-15

Family

ID=9349348

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88400693T ATE89281T1 (de) 1987-03-24 1988-03-23 Morpholin-derivate, deren verfahren zur herstellung und sie enthaltende pharmazeutische zusammensetzungen.

Country Status (17)

Country Link
US (1) US4782054A (de)
EP (1) EP0286495B1 (de)
JP (1) JPH0657709B2 (de)
AT (1) ATE89281T1 (de)
AU (1) AU600209B2 (de)
CA (1) CA1313870C (de)
DE (1) DE3880874T2 (de)
DK (1) DK171580B1 (de)
ES (1) ES2006390A6 (de)
FR (1) FR2612926B1 (de)
GR (1) GR1000241B (de)
HK (1) HK57297A (de)
IE (1) IE61882B1 (de)
NZ (1) NZ223984A (de)
OA (1) OA08822A (de)
PT (1) PT87061B (de)
ZA (1) ZA882107B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2653999A1 (fr) * 1989-11-06 1991-05-10 Adir Nouveaux derives de la morpholine, leur procede de preparation et les compositions pharmaceutiques les renfermant.
US6048859A (en) 1992-06-29 2000-04-11 Merck & Co., Inc. Morpholine and thiomorpholine tachykinin receptor antagonists
US5719147A (en) * 1992-06-29 1998-02-17 Merck & Co., Inc. Morpholine and thiomorpholine tachykinin receptor antagonists
US5637699A (en) * 1992-06-29 1997-06-10 Merck & Co., Inc. Process for preparing morpholine tachykinin receptor antagonists
TW385308B (en) * 1994-03-04 2000-03-21 Merck & Co Inc Prodrugs of morpholine tachykinin receptor antagonists
BRPI0510453A (pt) * 2004-04-30 2007-10-30 Warner Lambert Co composto substituìdos com morfolina para o tratamento de distúrbios do sistema nervoso central
GB0409744D0 (en) * 2004-04-30 2004-06-09 Pfizer Ltd Novel compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1138405A (en) * 1966-12-28 1969-01-01 Ici Ltd Morpholine derivatives
BE758766A (fr) * 1969-11-17 1971-05-10 Ici Ltd Nouveaux derives de la morpholine et de la

Also Published As

Publication number Publication date
JPH0657709B2 (ja) 1994-08-03
GR880100179A (en) 1989-01-31
ES2006390A6 (es) 1989-04-16
GR1000241B (el) 1992-05-12
DE3880874T2 (de) 1993-12-23
AU1352088A (en) 1988-09-22
OA08822A (fr) 1989-03-31
DK171580B1 (da) 1997-02-03
CA1313870C (fr) 1993-02-23
FR2612926A1 (fr) 1988-09-30
JPS63255279A (ja) 1988-10-21
PT87061A (pt) 1988-04-01
EP0286495A1 (de) 1988-10-12
ZA882107B (en) 1989-06-28
EP0286495B1 (de) 1993-05-12
AU600209B2 (en) 1990-08-02
US4782054A (en) 1988-11-01
DE3880874D1 (de) 1993-06-17
PT87061B (pt) 1992-07-31
IE61882B1 (en) 1994-11-30
IE880851L (en) 1988-09-24
NZ223984A (en) 1990-05-28
DK150088A (da) 1988-09-25
HK57297A (en) 1997-05-09
FR2612926B1 (fr) 1989-06-09
DK150088D0 (da) 1988-03-18

Similar Documents

Publication Publication Date Title
DE3775882D1 (de) Substituierte 6-fluor-4-oxo-1,4-dihydrochinolin-3-carbonsaeuren ; deren derivate; diese verbindung enthaltende pharmazeutische zubereitungen und verfahren zur herstellung dieser verbindungen.
ATE89281T1 (de) Morpholin-derivate, deren verfahren zur herstellung und sie enthaltende pharmazeutische zusammensetzungen.
ATE9472T1 (de) Amino-desoxy-1.4; 3.6-dianhydro-hexit-nitrate, verfahren zu ihrer herstellung und pharmazeutische zubereitung.
ATE3429T1 (de) Paromomycin-derivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammenzetzung.
AU610173B2 (en) New spiro (4,5) decane derivatives, process for the preparation thereof, and pharmaceutical compositions containing them
FR2703048B1 (fr) Nouveaux composes n-benzylpiperazine, leur procede de preparation et les compositions pharmaceutiques les renfermant.
HUT48464A (en) Process for producing pharmaceutical composition for treating hypertonia and cardiac failure
ATE104976T1 (de) Morpholinderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
ATE119149T1 (de) Pyrrolidonderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel.
HUT46909A (en) Process for production of substituated quinoxanileimidasoline-2,4-dions and medical preparatives containing such compositions
SE7906681L (sv) Ftalazonderivat
ZA807789B (en) Piperidine derivatives,their preparation,and pharmaceutical formulations containing these compounds
IL85229A0 (en) Novel imidazo-and triazolothiadiazines,a process for the preparation thereof,pharmaceutical compositions containing same,and the use thereof
DE3680893D1 (de) Pyrimido(5,4-b)(1,4)oxazinderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel sowie zwischenprodukte darstellende pyrimido(5,4-b)(1,4)oxazinderivate.
ZA948515B (en) Cyclised analogues of fatty acid metabolites,a process for their preparation and pharmaceutical compositions containing them
FR2592653A1 (fr) Derives de chromene, procede d'obtention et compositions pharmaceutiques.
DE3377415D1 (en) Novel phenylpiperazine derivatives, process for preparing them and therapeutic compositions containing them